Bharat Biotech gets nasal vaccine nod for use as mix-match booster- QHN
Bharat Biotech’s intranasal Covid-19 vaccine iNCOVACC has received the Indian drug regulator’s nod to be used as a heterologous booster […]
Moderna misses Q3 expectations, net income dips 69%; defers vaccine sales- QHN
Sliding COVID-19 vaccine sales and rising expenses for Moderna combined to produce a third quarter that missed Wall Street expectations. […]